Molecular formula: C152H252N44O42
Effects exerted by IPA include, but are not limited to, modulation of oxidative stress and inflammation as a result of increased expression of the cytochrome P450 enzymes encoded by the CYP1A1 and CYP1B1 genes and decreased expression of the interleukin-6 (IL-6) gene, promotion of intestinal mucosal barrier integrity, enhancement of mucosal anti-inflammatory IL-22 production, enhancement of mitochondrial fatty acid and amino acid oxidation in CD4 + T-cells resulting in reduced intestinal inflammation, and repression of nicotinamide N -methyltransferase (NNMT) activity resulting in enhanced nicotinamide, NAD + /NADH, and SIRT3 levels in the heart
For semaglutide specifically, cessation is advised at least 2 months before a planned pregnancy due to its long half-life

A SYSTEMATIC REVIEW Emilie Schou *1 , Andrea Harriott 2 , Cenk Ayata 3 , Anders Hougaard 4 1 Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark, 2 Neurovascular Research Laboratory, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA, Vascular Division, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA, Headache and Neuropathic Pain Division, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA, Boston, United States, 3 Vascular Division, Department of Neurology, Massachusetts General Hospital, Neurovascular Research Laboratory, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA, Boston, United States, 4 Department of Neurology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, Herlev, Denmark Background and Aims: Migrainous infarction is a rare complication of migraine with aura defined as an ischemic stroke that occurs during a migraine attack, potentially due to spreading depolarization-related hypoperfusion
